FAIRMOUNT FUNDS MANAGEMENT LLC – BioCryst Pharmaceuticals, Inc. Transaction History
FAIRMOUNT FUNDS MANAGEMENT LLC portfolio value:
$32.04M
portfolio value
FAIRMOUNT FUNDS MANAGEMENT LLC quarter portfolio value change:
+19.09%
quarter
BioCryst Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -23.93% | -800K shares | -3.32M | $12.6 | 2.54M |
Q2 2022 | share | Increase | 0.00% | 3.34M shares | 35.37M | $10.58 | 3.34M |